Loading viewer...
earnings
Format: PDF earnings
Pfizer's fourth quarter 2022 earnings teleconference presentation delivered January 31, 2023, includes forward-looking statements on financial performance, product pipeline developments, and strategic initiatives. The presentation discusses COVID-19 vaccine and treatment contributions, including Comirnaty and Paxlovid, alongside broader pharmaceutical portfolio performance and operational updates.
investor_presentation
16 Pages
earnings
24 Pages
Alfa Laval